Soliris
| Soliris | |
|---|---|
| Term | Soliris |
| Short definition | Soliris - (pronounced) (so-LAYR-is) drug used to prevent red blood cell destruction in patients with a rare red blood cell disorder called paroxysmal nocturnal hemoglobinuria (PNH). It is also used to treat another rare condition called atypical urea haemolytic syndrome (aHUS), in which blood clots form in small blood vessels. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Soliris - (pronounced) (so-LAYR-is) drug used to prevent red blood cell destruction in patients with a rare red blood cell disorder called paroxysmal nocturnal hemoglobinuria (PNH). It is also used to treat another rare condition called atypical urea haemolytic syndrome (aHUS), in which blood clots form in small blood vessels. Soliris attaches to a protein in the immune system called C5. This helps prevent the breakdown of red blood cells and prevent blood clots from forming. Soliris is a type of monoclonal antibody. Also called eculizumab
External links
- Medical encyclopedia article on Soliris
- Wikipedia's article - Soliris
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski